Skip to content

A retrospective cohort study of digital therapeutics for hypertension.

A retrospective cohort study of digital therapeutics for hypertension. - A retrospective cohort study of digital therapeutics for hypertension.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052169
Enrollment
5000
Registered
2023-09-11
Start date
2023-09-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension

Interventions

None listed

Sponsors

Kanazawa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients who were prescribed CureApp HT between September 2022 and December 2025 and input their home blood pressure at least once.

Exclusion criteria

Exclusion criteria: - Patients who have indicated their refusal to provide information to the institutions of this study - Nonexistent data such as input for testing

Design outcomes

Primary

MeasureTime frame
Change from baseline in home blood pressure at 12 weeks of app use

Countries

Japan

Contacts

Public ContactAkihiro Nomura

Kanazawa University College of Transdisciplinary Sciences for Innovation / Department of Cardiovascular Medicine

anomura@med.kanazawa-u.ac.jp076-264-5920

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026